Genomics BioSci & Tech. Co.,Ltd.

TPEX:4195 Rapporto sulle azioni

Cap. di mercato: NT$1.3b

Genomics BioSci & Tech.Ltd Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Kevin Chiang

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Is Genomics BioSci & Tech. Co.,Ltd.'s (GTSM:4195) 7.2% Dividend Worth Your Time?

Apr 27
Is Genomics BioSci & Tech. Co.,Ltd.'s (GTSM:4195) 7.2% Dividend Worth Your Time?

Key Things To Consider Before Buying Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) For Its Dividend

Jan 19
Key Things To Consider Before Buying Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) For Its Dividend

Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Nov 25
Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

AMMINISTRATORE DELEGATO

Kevin Chiang

no data

Mandato

Kevin Chiang serves as Chief Executive Officer of Genomics BioSci & Tech Co.,Ltd. and previously served as its Vice General Manager. Kevin Chiang was Clinical Research Associate at Protech Pharmaservices C...